Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery
PUCTURE-NVPO
Randomized Clinical Trial to Evaluate the Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting (PONV) in Ambulatory Surgery
1 other identifier
interventional
270
1 country
1
Brief Summary
To evaluate the Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting (PONV) in Ambulatory Surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 26, 2011
CompletedFirst Posted
Study publicly available on registry
September 28, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedOctober 3, 2012
October 1, 2012
1.3 years
September 26, 2011
October 2, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of patients with a score <50 on the PONV Intensity Scale at 72 hours postoperatively.
The percentage of patients with a score \<50 on the PONV Intensity Scale (defined as clinically not significant PONV) at 72 hours postoperatively will be assessed in the experimental and control group, respectively. In the experimental group, patients receive cutaneous stimulation and self-stimulation of acupuncture points Pericardium 6, Heart 7 and Stomach 25. In the control (placebo) group, patients receive cutaneous stimulation and self-stimulation of acupuncture points Gall Bladder 34, Kidney 6 and Liver 3.
72 hours
Secondary Outcomes (6)
Percentage of patients with a score <50 on the PONV Intensity Scale at 6 and 24 hours postoperatively.
6 and 24 hours
Evaluation of the postoperative recovery outcome
24 hours
Evaluation of perioperative pain
72 hours
Assessment of the patient´s satisfaction with the perioperative care
72 hours
Assessment of costs and economic impact of the disease
72 hours
- +1 more secondary outcomes
Study Arms (2)
Group A
ACTIVE COMPARATORPatients receive cutaneous stimulation and self-stimulation of acupuncture points Pericardium 6, Heart 7 and Stomach 25
Group B
SHAM COMPARATORPatients receive cutaneous stimulation and self-stimulation of acupuncture points Gall Bladder 34, Kidney 6 and Liver 3
Interventions
The investigators will use ear seeds to stimulate acupuncture points. The seeds will be applied when the patients are in the preoperative room. After the patients have been discharged, they will need to stimulate these points every eight hours for five minutes, and every time they have nausea and/or vomiting during the first three postoperative days.
Eligibility Criteria
You may qualify if:
- Patients of both sexes, aged 18 years and older.
- ASA I-II patients who will undergo a surgical procedure under general anesthesia in an ambulatory setting.
- Patients who are anticipated to not require admission to the recovery room or intensive care unit.
- Patients who, according to clinical criteria of the acupuncturist physician, are likely to benefit from acupuncture.
- Patients with a sufficient educational level to complete the health questionnaires required in the study.
- Patients who have given their written informed consent to participate in the study.
You may not qualify if:
- Patients with any pathology that under medical discretion makes their participation in the study inadvisable.
- Patients who cannot respond to the questionnaires provided during the study.
- Patients with known hypersensitivity to the materials of the ear seeds.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Group G-6lead
Study Sites (1)
Fundacion Jimenez Diaz Hospital
Madrid, Madrid, 28040, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
PAULA ORTIZ LUCAS, MD
GRUPO G6
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2011
First Posted
September 28, 2011
Study Start
September 1, 2011
Primary Completion
December 1, 2012
Study Completion
April 1, 2013
Last Updated
October 3, 2012
Record last verified: 2012-10